Clinicopathological Factors Associated with Remnant or Regrowth of Benign Breast Tumor after Previous Vacuum-Assisted Core Biopsy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We sometimes encounter remnant or regrowth of benign breast tumors diagnosed as Breast Imaging-Reporting and Data System (BI-RADS) C4 in follow-up breast ultrasound after previous vacuum-assisted core biopsy (VACB). We aimed to evaluate the factors that influence remnant or regrowth tumors at post-VACB site or adjacent tissue. Methods: From January 2010 to December 2015, we analyzed 647 cases on follow-up. Patients were divided into two groups; group A was defined as patients without recurrent masses on breast ultrasonography during the follow-up period, and group B was defined as those with recurrent masses diagnosed as more than BI-RADS C4 on ultrasonography. Results: Fibrocystic changes, proliferative disease without atypia, intraductal papilloma, apocrine cell change, atypical ductal hyperplasia, sclerosing adenosis, and radial scars were observed in 89.5% (n=579), 15.9% (n=103), 15.3% (n=99), 5.3% (n=34), 5.7% (n=37), 7.6% (n=49), and 6.3% (n=41) of patients, respectively. During the follow-up period, 85 patients were diagnosed as group B. Group B was significantly associated with proliferative diseases without atypia, sclerosing adenosis, and microcalcifications compared to group A (p=0.008, p=0.007, and p=0.001, respectively). After adjustment for confounding variables, group B was more significantly associated with proliferative breast diseases than group A (hazard ratio [HR], 0.558; 95% confidence interval [CI], 0.343–0.907; p=0.018). Furthermore, group B was more significantly associated with intraductal papilloma (HR, 0.571; 95% CI, 0.342–0.953; p=0.032). Conclusion: Previously diagnosed proliferative diseases without atypia or microcalcification at first VACB were significantly associated with recurrent breast tumor. Intraductal papilloma was also significantly associated with tumor regrowth.
Abstract
Purpose: We sometimes encounter remnant or regrowth of benign breast tumors diagnosed as Breast Imaging-Reporting and Data System (BI-RADS) C4 in follow-up breast ultrasound after previous vacuum-assisted core biopsy (VACB). We aimed to evaluate the factors that influence remnant or regrowth tumors at post-VACB site or adjacent tissue. Methods: From January 2010 to December 2015, we analyzed 647 cases on follow-up. Patients were divided into two groups; group A was defined as patients without recurrent masses on breast ultrasonography during the follow-up period, and group B was defined as those with recurrent masses diagnosed as more than BI-RADS C4 on ultrasonography. Results: Fibrocystic changes, proliferative disease without atypia, intraductal papilloma, apocrine cell change, atypical ductal hyperplasia, sclerosing adenosis, and radial scars were observed in 89.5% (n=579), 15.9% (n=103), 15.3% (n=99), 5.3% (n=34), 5.7% (n=37), 7.6% (n=49), and 6.3% (n=41) of patients, respectively. During the follow-up period, 85 patients were diagnosed as group B. Group B was significantly associated with proliferative diseases without atypia, sclerosing adenosis, and microcalcifications compared to group A (p=0.008, p=0.007, and p=0.001, respectively). After adjustment for confounding variables, group B was more significantly associated with proliferative breast diseases than group A (hazard ratio [HR], 0.558; 95% confidence interval [CI], 0.343–0.907; p=0.018). Furthermore, group B was more significantly associated with intraductal papilloma (HR, 0.571; 95% CI, 0.342–0.953; p=0.032). Conclusion: Previously diagnosed proliferative diseases without atypia or microcalcification at first VACB were significantly associated with recurrent breast tumor. Intraductal papilloma was also significantly associated with tumor regrowth.
참고문헌 (19)
- Yamaguchi R, "Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies", Histopathology, 66, pp.565~576 (2015)
- Preibsch H, "Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary?", Acta Radiol, 56, pp.1078~1084 (2015)
- Debi U, "Role of directional vacuum assisted breast biopsy in previously equivocal biopsies for breast masses suspicious for malignancy", Malays J Pathol, 37, pp.25~33 (2015)
- Choi ER, "Initial experience with a wireless ultrasound-guided vacuum-assisted breast biopsy device", PLoS One, 10, pp.e0144046~ (2015)
- Xu Y, "Mammotome-assisted endoscopic breast-conserving surgery: a novel technique for early-stage breast cancer", World J Surg Oncol, 12, pp.99~ (2014)
- Pan S, "Ultrasound-guided vacuum-assisted breast biopsy using Mammotome biopsy system for detection of breast cancer: results from two high volume hospitals", Int J Clin Exp Med, 7, pp.239~246 (2014)
- Cheng J, "Benign breast disease heterogeneity: association with histopathology, age, and ethnicity", Breast Cancer Res Treat, 111, pp.289~296 (2008)
- Yi W, "Completely removing solitary intraductal papillomas using the Mammotome system guided by ultrasonography is feasible and safe", World J Surg, 37, pp.2613~2617 (2013)
- Jaffer S, "Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised", Breast J, 19, pp.130~133 (2013)
- Wang K, "The Mammotome biopsy system is an effective treatment strategy for breast abscess", Am J Surg, 205, pp.35~38 (2013)
- Soumian S, "Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS)", Eur J Surg Oncol, 39, pp.1337~1340 (2013)
- Order BM, "Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G", 8G vs. ATEC(R) system 12G, Acta Radiol, pp.2013, 54[DOI]
- Kibil W, "Vacuum-assisted core biopsy in diagnosis and treatment of intraductal papillomas", Clin Breast Cancer, 13, pp.129~132 (2013)
- Jiang Y, "Mammotome(®) biopsy system for the resection of breast lesions: clinical experience in two high-volume teaching hospitals", Exp Ther Med, 6, pp.759~764 (2013)
- Ding B, "Meta analysis of efficacy and safety between Mammotome vacuum-assisted breast biopsy and open excision for benign breast tumor", Gland Surg, 2, pp.69~79 (2013)
- Wang ZL, "Percutaneous excisional biopsy of clinically benign breast lesions with vacuum-assisted system: comparison of three devices", Eur J Radiol, 81, pp.725~730 (2012)
- Abbate F, "Ultrasound-guided vacuum-assisted breast biopsy: use at the European Institute of Oncology in 2010", J Ultrasound, 14, pp.177~181 (2011)
- Połom K, "Vacuum-assisted core-needle biopsy as a diagnostic and therapeutic method in lesions radiologically suspicious of breast fibroadenoma", Rep Pract Oncol Radiother, 16, pp.32~35 (2010)
- Wei H, "Ultrasound-guided vacuum-assisted breast biopsy system for diagnosis and minimally invasive excision of intraductal papilloma without nipple discharge", World J Surg, 33, pp.2579~2581 (2009)
